Amit Sachdev
CIK 1406338 · EVP Chief Patient & Ext Af Off · last filed 2026-07-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$40.03M
Companies
2
Total Filings
156
Lifetime Open-Market Net
-$171.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | EVP Chief Patient & Ext Af Off | 73,149 | $547.18 | $40.03M | -$171.36M | 142 | 2026-07-23 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Director | 533 | $1.73 | $919 | $0 | 5 | 2023-03-03 |
Recent Filings · Page 15 of 16
156 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-01-13 | VRTX | Sell (S) | −451 | -$17.0K | EDGAR |
| 2010-10-29 | VRTX | Sell (S) | −4,750 | -$182.9K | EDGAR |
| 2010-10-28 | VRTX | Sell (S) | −4,534 | -$170.0K | EDGAR |
| 2010-10-20 | VRTX | Sell (S) | −1,000 | -$36.5K | EDGAR |
| 2010-10-18 | VRTX | Sell (S) | −1,000 | -$35.0K | EDGAR |
| 2010-07-16 | VRTX | Grant (A) | — | $0 | EDGAR |
| 2010-02-08 | VRTX | Grant (A) | +10,166 | $102 | EDGAR |
| 2009-10-26 | VRTX | Grant (A) | — | $0 | EDGAR |
| 2009-07-20 | VRTX | Grant (A) | — | $0 | EDGAR |
| 2009-05-19 | VRTX | Sell (S) | −783 | -$22.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.